胰岛素受体激酶的整合动态揭示了III型全囊口袋
Jyoti Verma1, Harish Vashisth1,2,3,4
1Department of Chemical Engineering and Bioengineering, University of New Hampshire, Durham, New Hampshire, United States.
Protein science : a publication of the Protein Society
|January 20, 2026
概括
研究人员在胰岛素受体激酶 (IRK) 中特征了III型全囊,揭示了关键的残留物和抑制剂结合机制. 这项工作有助于设计受体氨酸激酶受体的选择性全调节器.
科学领域:
- 生物化学和结构生物学
- 药理学和药物发现
背景情况:
- 阿洛斯特基调制提供了选择性激酶抑制的策略.
- 人类基因组中的全囊结构数据有限.
研究的目的:
- 描述胰岛素受体激酶 (IRK) 中的III型全囊.
- 阐明所有菌抑制剂与IRK结合的结构和热力学基础.
主要方法:
- 微秒级的原子分子动力学模拟.
- 无化学的自由能量计算.
- 分子力学与一般化Born表面积 (MMPBSA) 计算.
主要成果:
- 在IRK中,III类口袋是一种疏水的"背口袋",由特定的残留物稳定.
- 一种全抑制剂采用了转移稳定的构造,通过与αC螺旋和V1060.0的相互作用来稳定.
- M1051,F1054,V1060,F1128和E1043被确定为关键的残留热点.
- M1051作为一个守门者残留物,调节抑制剂结合和αC螺旋体完整性.
- 在apo和抑制剂结合状态中观察到稳定的"DFG-out"形状.
结论:
- 详细的机械洞察力揭示了所有菌抑制剂与IRK结合的详细机制.
- 阐明了IRK类型III口袋的结构特征.
- 这些发现有助于设计受体氨酸激酶受体的选择性全调节剂.
相关概念视频
Cooperative Allosteric Transitions
8.6K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.6K
Cooperative Allosteric Transitions
2.6K
2.6K
Protein Kinases and Phosphatases
15.0K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.0K
Receptor Tyrosine Kinases
18.2K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.2K
Insulin Formulations: Types and Delivery
670
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
670
Insulin: The Receptor and Signaling Pathways
2.8K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.8K


